Assessment of open label co-stimulation blockade with abatacept in children and adolescents with active juvenile idiopathic arthritis (JIA).

被引:0
|
作者
Lovell, Daniel J.
Ruperto, Nicolino
Prieur, Anne-Marie
Paz, Eliana
Pérez, Nadina Eugenia Rubio
Silva, Clovis A.
Mendoza, Carlos Abud
Burgos-Vargas, Ruben
Magalhaes, Claudia
Melo-Gomes, Jose A.
Gerloni, Valeria
Sztajnbok, Flavio R.
Scheinberg, Morton
Sigal, Leonard
Block, Alan
Zhou, Ye
Cornet, Patricia L.
Pagliaro, Lori
Giannini, Edward
Martini, Alberto
机构
[1] Cincinnati Childrens Hosp Med Ctr, PRCSG, Cincinnati, OH USA
[2] Ist Giannina Gaslini, IRCCS, PRINTO, I-16148 Genoa, Italy
[3] Bristol Myers Squibb Co, Princeton, NJ USA
来源
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S326 / S326
页数:1
相关论文
共 50 条
  • [41] Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis
    Vojinovic, Jelena
    Foeldvari, Ivan
    Dehoorne, Joke
    Panaviene, Violeta
    Susic, Gordana
    Horneff, Gerd
    Stanevicha, Valda
    Kobusinska, Katarzyna
    Zuber, Zbigniew
    Dobrzyniecka, Bogna
    Akikusa, Jonathan
    Avcin, Tadej
    Borlenghi, Cecilia
    Arthur, Edmund
    Tatulych, Svitlana Y.
    Zang, Chuanbo
    Tsekouras, Vassilis
    Vlahos, Bonnie
    Martini, Alberto
    Ruperto, Nicolino
    RHEUMATOLOGY, 2024, 63 (01) : 140 - 148
  • [42] An Open-Label Extension Study to Assess the Long-Term Safety and Clinical Benefit of Etanercept on Children and Adolescents with Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, or Psoriatic Arthritis: A 4-Year Update
    Ruperto, Nicolino
    Constantin, Tamas
    Foeldvari, Ivan
    Vojinovic, Jelena
    Horneff, Gerd
    Burgos-Vargas, Ruben
    Nikishina, Irina
    Akikusa, Jonathan
    Avcin, Tadej
    Chaitow, Jeffrey
    Koskova, Elena
    Lauwerys, Bernard R.
    Calvo-Penedes, Inmaculada
    Flato, Berit
    Gamir Gamir, Maria Luz
    Huppertz, Hans-Iko
    Jaller Raad, Juan Jose
    Jarosova, Katerina
    Anton, Jordi
    Macku, Marie
    Otero Escalante, William Jose
    Rutkowska-Sak, Lidia
    Trauzeddel, Ralf
    Wouters, Carine
    Pedersen, Ronald
    Kotak, Sameer
    Bukowski, Jack F.
    Hinnershitz, Tina
    Vlahos, Bonnie
    Martini, Alberto
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [43] Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study
    Brunner, Hermine I.
    Pacheco-Tena, Cesar
    Louw, Ingrid
    Vega-Cornejo, Gabriel
    Alexeeva, Ekaterina
    Appenzeller, Simone
    Chasnyk, Vyacheslav
    Griffin, Thomas
    Suarez, Carmen Navarrete
    Knupp-Oliveira, Sheila
    Zeft, Andrew
    Aviel, Yonatan Butbul
    De Ranieri, Deirdre
    Gottlieb, Beth S.
    Levy, Deborah M.
    Rabinovich, C. Egla
    Silva, Clovis Artur
    Spivakovsky, Yury
    Uziel, Yosef
    Ringold, Sarah
    Xu, Xie L.
    Leu, Jocelyn H.
    Lam, Edwin
    Wang, Yuhua
    Lovell, Daniel J.
    Martini, Alberto
    Ruperto, Nicolino
    JOURNAL OF RHEUMATOLOGY, 2024, 51 (11) : 1125 - 1134
  • [44] A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
    Ruperto, Nicolino
    Quartier, Pierre
    Wulffraat, Nico
    Woo, Patricia
    Ravelli, Angelo
    Mouy, Richard
    Bader-Meunier, Brigitte
    Vastert, Sebastiaan J.
    Noseda, Emanuele
    D'Ambrosio, Daniele
    Lecot, Jean
    Chakraborty, Abhijit
    Martini, Alberto
    Chioato, Andrea
    ARTHRITIS AND RHEUMATISM, 2012, 64 (02): : 557 - 567
  • [45] Growth In Children and Adolescents With Juvenile Idiopathic Arthritis (JIA) After 2 Years Of Treatment With Etanercept: Results From The British Society For Paediatric and Adolescent Rheumatology (BSPAR) Etanercept Cohort Study
    Kearsley-Fleet, Lianne
    Davies, Rebecca
    Lunt, Mark
    Hyrich, Kimme L.
    Southwood, Taunton R.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S122 - S123
  • [46] Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement
    Patricia Woo
    Nicholas Wilkinson
    Anne-Marie Prieur
    Taunton Southwood
    Valentina Leone
    Polly Livermore
    Helena Wythe
    David Thomson
    Tadamitsu Kishimoto
    Arthritis Research & Therapy, 7
  • [47] Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement
    Woo, P
    Wilkinson, N
    Prieur, AM
    Southwood, T
    Leone, V
    Livermore, P
    Wythe, H
    Thomson, D
    Kishimoto, T
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (06) : R1281 - R1288
  • [48] Summary of Research: Ten-Year Safety and Clinical Benefit from Open-Label Etanercept Treatment in Children and Young Adults with Juvenile Idiopathic Arthritis
    Vojinovic, Jelena
    Foeldvari, Ivan
    Dehoorne, Joke
    Panaviene, Violeta
    Susic, Gordana
    Horneff, Gerd
    Stanevica, Valda
    Kobusinska, Katarzyna
    Zuber, Zbigniew
    Dobrzyniecka, Bogna
    Avcin, Tadej
    Borlenghi, Cecilia
    Arthur, Edmund
    Zang, Chuanbo
    Tsekouras, Vassilis
    Vlahos, Bonnie
    Martini, Alberto
    Ruperto, Nicolino
    RHEUMATOLOGY AND THERAPY, 2024, 11 (06) : 1437 - 1440
  • [49] Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study
    Brunner, Hermine, I
    Quartier, Pierre
    Alexeeva, Ekaterina
    Constantin, Tamas
    Kone-Paut, Isabelle
    Marzan, Katherine
    Schneider, Rayfel
    Wulffraat, Nico M.
    Chasnyk, Vyacheslav
    Tirosh, Irit
    Kallinich, Tilmann
    Kuemmerle-Deschner, Jasmin
    Wouters, Carine
    Lauwerys, Bernard
    Nikishina, Irina
    Trachana, Maria
    Vougiouka, Olga
    Martini, Alberto
    Lovell, Daniel J.
    Levy, Jeremy
    Vritzali, Eleni
    Ruperto, Nicolino
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (12) : 2147 - 2158
  • [50] Efficacy of infusions of an anti Tnfα antibody (infliximab) in persistently active refractory juvenile idiopathic arthritis. results of a two years open label prospective study.
    Gerloni, V
    Lurati, A
    Gattinara, M
    Pontikaki, I
    Fantini, F
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S92 - S92